XML 34 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (USD $)
Mar. 31, 2013
Sep. 30, 2012
CURRENT ASSETS    
Cash and cash equivalents $ 3,313,483 $ 3,377,288
Trade receivable   9,375
Other receivables   9,930
Prepaid expenses and other current assets 426,398 618,130
Marketable securities   106,500
Note receivable, net   2,446,113
TOTAL CURRENT ASSETS 3,739,881 6,567,336
PROPERTY AND EQUIPMENT    
Computers, office equipment and furniture 323,376 323,376
Research equipment 3,186,601 3,319,027
Software 69,623 69,623
Leasehold improvements 2,749,409 2,749,409
Property, Plant and Equipment, Gross, Total 6,329,009 6,461,435
Less: Accumulated depreciation and amortization (2,315,915) (1,565,783)
PROPERTY AND EQUIPMENT, NET 4,013,094 4,895,652
OTHER ASSETS    
Patents and other intangible assets, net 4,636,339 4,784,569
Derivative asset and other non-current assets 30,011 280,261
TOTAL OTHER ASSETS 4,666,350 5,064,830
TOTAL ASSETS 12,419,325 16,527,818
CURRENT LIABILITIES    
Accounts payable 871,707 877,986
Accrued expenses 823,517 730,775
Accrued payroll and benefits 1,222,573 1,127,219
Deferred revenue 65,625 37,500
Derivative liabilities 2,535,910 647,213
Capital lease obligation 218,048 214,801
Notes payable 880,239 100,000
Other current liabilities 546,407 1,592,394
TOTAL CURRENT LIABILITIES 7,164,026 5,327,888
LONG-TERM LIABILITIES    
Notes payable, net of current portion 50,000 839,421
Capital lease obligation, net of current portion 1,172,616 1,282,458
Other non-current liabilities 272,179 269,142
TOTAL LONG-TERM LIABILITIES 1,494,795 2,391,021
Commitments and contingencies      
STOCKHOLDERS' EQUITY    
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued or outstanding      
Common stock, $0.001 par value; 145,000,000 shares authorized; 17,042,764 and 13,579,185 shares issued and outstanding as of March 31, 2013 and September 30, 2012, respectively 109,402 108,354
Additional paid-in capital 151,573,260 145,917,968
Subscription receivable   (1,016,000)
Accumulated deficit during the development stage (146,369,775) (134,997,680)
Total Arrowhead Research Corporation stockholders' equity 5,312,887 10,012,642
Noncontrolling interest (1,552,383) (1,203,733)
TOTAL STOCKHOLDERS' EQUITY 3,760,504 8,808,909
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 12,419,325 $ 16,527,818